Jason Hulse Murray
CIK 2014386 · Co-Founder, CEO & Chairman · last filed 2026-11-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PACS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
262 N. UNIVERSITY AVENUE
FARMINGTON, UT 84025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PACS | Co-Founder, CEO & Chairman | 63,436,279 | $48.87 | $3.10B | -$380.85M | 18 | 2026-11-09 |
Recent Filings · Page 2 of 3
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-10 | PACS | Notice (144) | −253,333 | -$11.21M | EDGAR |
| 2026-09-09 | PACS | Sell (S) | −51,887 | -$2.24M | EDGAR |
| 2026-09-03 | PACS | Sell (S) | −68,113 | -$2.90M | EDGAR |
| 2026-09-01 | PACS | Notice (144) | −120,000 | -$5.07M | EDGAR |
| 2026-08-24 | PACS | Sell (S) | −150,550 | -$6.61M | EDGAR |
| 2026-08-19 | PACS | Sell (S) | −236,116 | -$10.44M | EDGAR |
| 2026-08-17 | PACS | Notice (144) | −386,666 | -$16.89M | EDGAR |
| 2026-03-26 | PACS | Grant (A) | +234,397 | $0 | EDGAR |
| 2026-01-20 | PACS | Tax (F) | −20,082 | -$793.0K | EDGAR |
| 2025-12-19 | PACS | Grant (A) | +241,018 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.